Spinal Anesthesia Clinical Trial
Official title:
A Randomized Controlled Trial Evaluating the Effect of Intravenous Dexamethasone on the Duration of Spinal Anesthesia as Part of a Multimodal Antiemetic Strategy for Enhanced Recovery After Cesarean Delivery
The goal of this clinical trial is to determine the effects of intravenous (IV) dexamethasone on spinal anesthesia in healthy women having an elective Cesarean delivery (CD) at the IWK Health Centre. The main questions it aims to answer are: 1. What effect does IV dexamethasone have on the resolution of motor blockade in patients having spinal anesthesia for elective CDs? 2. What effect does IV dexamethasone have on the sensory recovery of spinal blockade, the total hydromorphone requirement in the first 24 h postoperatively, the incidence of pruritis perioperatively, and the incidence of nausea and vomiting? The spinal anesthesia technique will be standardized and will be administered as per routine care at IWK Health. Computer generation will randomize patients to either Group SD, who will receive IV dexamethasone, or group SM who will receive IV metoclopramide, an alternative anti-emetic, immediately after spinal anesthesia by the attending anesthesia provider. Each patient will receive ondansetron, a second anti- emetic as recommended for Enhanced Recovery After Surgery (ERAS) protocol. Participant sensation, pain, nausea, pruritus, and motor blockade will be assessed in recovery. The patient's sensation and Bromage score will be assessed every 15 minutes until sensation is reached at L3 and a Bromage score of 4 is achieved. The investigators will determine if there is a difference between groups regarding motor blockade, the length of time of spinal anesthesia, and side effects after CD.
Status | Recruiting |
Enrollment | 192 |
Est. completion date | December 2024 |
Est. primary completion date | April 2024 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Non-emergent Caesarean Delivery with planned spinal anesthesia - American Society of Anesthesia physical status class < III - Age =18 years - Term gestational age (=37weeks) - Singleton pregnancy - Moderate English language fluency Exclusion Criteria: - Obesity (BMI = 45kg/m2) - Height < 5'0" - Patients with significant obstetric or neonatal co-morbidities (i.e., severe maternal cardiac disease, preeclampsia, fetal anomalies) - Opioid tolerance or sensitivity - Intolerance to non-steroidal anti-inflammatory drugs (NSAIDs) - Contraindication to neuraxial analgesia (i.e., coagulopathy, infection, neuropathy) - Abnormal spinal anatomy (i.e., severe scoliosis, spina bifida, spinal instrumentation) - Use of chronic steroids - A physical or psychiatric condition which impairs cooperation |
Country | Name | City | State |
---|---|---|---|
Canada | IWK Health Centre | Halifax | Nova Scotia |
Lead Sponsor | Collaborator |
---|---|
IWK Health Centre |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Resolution of motor blockade assessed by the Bromage motor blockade score | A Bromage score is quantified from 1 to 4, where a score of 1 indicates a complete block and patients are unable to move their feet or knees. A score of 2 indicates patients are able to only move their feet, while a score of 3 indicates slight knee movement and movement of the feet. A score of 4 indicates full flexion of the knees and feet. When a Bromage score of 3 is reached, assessments will instead occur every 3-5 minutes until a Bromage of 4 is achieved and confirmed bilaterally with a second assessment 1-minute later. If needed, assessments will continue to occur every 3-5 minutes until a Bromage score of 4 is reached bilaterally. The time will be recorded to specify the hour and minute of each assessment. A Bromage score of 4 indicates the endpoint. | Upon entrance to PACU until a Bromage score of 4 is achieved bilaterally | |
Secondary | Sensory recovery of spinal blockade assessed by dermatome testing | Dermatome assessments using ice will occur every 15-minutes unilaterally. When sensation is reached at L3 (the greater trochanter region of the femur), a bilateral assessment will be taken, and the time will be recorded. If needed, assessments will continue to occur until sensation has been reached at L3 bilaterally. The time will be recorded to specify the hour and minute of each assessment. | Upon entrance to PACU until sensory is achieved bilaterally at L3 | |
Secondary | Total opioid requirement (mg) in the first 24 hours postoperatively | Recorded from the Intraoperative Anesthesia Information Management System (in milligrams, mg). | Retrieved at 24 hours following spinal anesthesia. | |
Secondary | Pain scores assessed by NRS | Numeric Rating Scale (NRS) is quantified as 0-10, where 0 is none, 1-3 is mild, 4-6 is moderate, and 7-10 is severe, where 10 represents the worst pain imaginable. | Every hour postoperatively until a Bromage score of 4 is achieved. | |
Secondary | Nausea intensity scores assessed by NRS | Numeric Rating Scale (NRS) is quantified as 0-10, where 0 is none, 1-3 is mild, 4-6 is moderate, and 7-10 is severe, where 10 represents the worst nausea intensity imaginable. | Every hour postoperatively until a Bromage score of 4 is achieved. | |
Secondary | Incidence of pruritis (itching) | Assessed by asking participants "yes" or "no" | Post-operatively at time of PACU discharge | |
Secondary | Incidence of vomiting | Assessed by asking participants "yes" or "no" | Post-operatively at time of PACU discharge |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02565303 -
Minimum Effective Dose of Ropivacaine for Spinal Anesthesia for Cesarean Delivery
|
N/A | |
Recruiting |
NCT03248817 -
Phenylephrine Infusion in Cesarean Delivery
|
Phase 4 | |
Completed |
NCT02840006 -
Spinal Anesthesia Associated With General Anesthesia in Coronary Artery Bypass
|
Phase 4 | |
Completed |
NCT01624844 -
Predictive Value of Ultrasound Measurement of the Dural Sac Volume on the Sensory Level in Spinal Anesthesia
|
N/A | |
Recruiting |
NCT00974961 -
Levobupivacaine on Heart Rate Variability (HRV) in Spinal Anesthesia
|
Phase 4 | |
Recruiting |
NCT00492453 -
Spinal Versus General Anesthesia for Laparoscopic Cholecystectomy
|
N/A | |
Completed |
NCT05549011 -
PENG vs SIFI Block for Positioning Pain During Spinal Anesthesia
|
||
Completed |
NCT03805503 -
Chloroprocaine for Inguinal Herniorrhaphy
|
Phase 4 | |
Completed |
NCT03775655 -
Low Dose Hyperbaric Bupivacaine and Dexmedetomidine as an Adjuvant, Caesarean Section
|
Phase 2/Phase 3 | |
Completed |
NCT03199170 -
Effect of Bilateral Quadratus Lumborum Block for Pain Relief in Patients With Cesarean Section
|
N/A | |
Completed |
NCT03302039 -
Three Protocols for Phenylephrine Administration in Cesarean Delivery
|
Phase 4 | |
Not yet recruiting |
NCT05063292 -
Effect of Prewarming On Skin Temperature Changes
|
N/A | |
Not yet recruiting |
NCT05583214 -
Evaluating the Effectiveness of Ondansetron Versus Dexamethasone Versus Placebo for the Control of Intraoperative Nausea and Vomiting in Patients Undergoing Lower-segment Caesarean Section Under Spinal Anesthesia
|
Phase 4 | |
Recruiting |
NCT02937792 -
Large Volume Bupivacaine 0.5% Versus Small Volume in Elective Caesarean Section
|
N/A | |
Recruiting |
NCT01415284 -
ED50 Determination of Hydroxyethylstarch for Treatment of Hypotension During Cesarean Section Under Spinal Anesthesia
|
Phase 4 | |
Completed |
NCT00537472 -
Low Dose Spinal Bupivacaine for Total Knee Replacement and Recovery Room Wait Time
|
N/A | |
Completed |
NCT05548985 -
Midodrine for Prophylaxis Against Post Spinal Hypotension in Elderly Population
|
N/A | |
Completed |
NCT03322098 -
Effect of Atropine or Glycopyrrolate on the Prevention of Bradycardia During Sedation Using Dexmedetomidine in Geriatric Patients Undergoing Total Knee Replacement Under Spinal Anesthesia
|
N/A | |
Recruiting |
NCT04598061 -
IV Dexmedetomidine as Spinal Anesthesia Adjuvant in Infants
|
||
Completed |
NCT04083768 -
Effect of Different Left Lateral Table Tilt for Elective Cesarean Delivery Under Spinal Anesthesia
|
N/A |